多發性骨髓瘤教育研討會

項目內容
時間2020-08-30的12:30至15:30
類型甲類
積分3
主辦單位台灣安進藥品有限公司 、中華民國血液病學會
會議地點視訊(不限額)+現場視訊(限額20人,需事先登記)
安進公司邀請本會於8/30(日)12:30-15:30合辦「多發性骨髓瘤教育研討會」,此場會議會做hybrid (現場視訊+視訊)。
(1)現場視訊(會議地點:台北;已另e-mail通知會員):限額20人,請會員填下面表單,透過網路報名,恕不受理e-mail或電話或傳真報名。將以網路報名先後順序,錄取前20位報名者,額滿即截止報名,欲報從速。
(2)視訊:不限額,請另至官網報名,註冊網址: https://onemediachannel.com/event/register/AMGENMETA2020 。註冊後會收到Email通知,內有會議連結,於線上研討會開始時點擊即可進入會議室。

[註]參加現場視訊會議,有事先報名及到場親自簽到者,可獲教育學分(血液病學會甲類3分、癌症醫學會A類2分、骨髓移植學會1.5分);僅透過視訊參與者,無法累積教育學分,請見諒!


Co-chairs:Meletios Dimopoulos (Greece); Jeffrey Huang (Taiwan)
Regional Faculty:
Hang Quach (Australia)
Steering Committee Faculty:Wee Joo Chng (Singapore); Suporn Chuncharunee (Thailand); Simon Harrison (Australia);
Jeffrey Huang (Taiwan);Jin-Seok Kim (South Korea)
Time Session Faculty
12:30-12:35 Opening and Welcome Co-chairs:
Jeffrey Huang (Taiwan)
Meletios Dimopoulos (Greece)
Focus on Early Multiple Myeloma
12:35-12:50 Identifying Patients at Risk Meletios Dimopoulos (Greece)
12:50-13:05 Initial Treatment for NDMM Hang Quach (Australia)
Assessing Treatment Options to Best Meet Your RRMM Patient’s Needs
13:05-13:40 How I Treat RRMM Myeloma Patients
Followed by Q&A session
Wee Joo Chng (Singapore) Meletios Dimopoulos (Greece)
13:40-14:00 Novel Therapies: What Could be the Impact?
Followed by Q&A Session
Simon Harrison (Australia)
14:00-14:10 Refreshment Break All Faculty
COVID-19 and Multiple Myeloma Treatment
14:10-14:20 Advice from HemeOnc Professional Bodies for Managing Multiple Myeloma Patients Wee Joo Chng (Singapore)
14:20-14:30 Q&A Session All Faculty
Concomitant Treatment and Adverse Events Management
14:30-14:50 Therapeutic Strategies for Treating Bone Disease
Followed by Q&A Session
Jeffrey Huang (Taiwan)
14:50-15:35 Awareness of Treatment Emergent Adverse Events and Underlying Comorbidities in RRMM
3 x Patient Cases
Wee Joo Chng (Singapore) Jin-Seok Kim (South Korea) Suporn Chuncharunee (Thailand)
15:35-15:45 Meeting Summary and Close Jeffrey Huang (Taiwan)